Virtu KCG Holdings’s Kindred Biosciences, Inc. KIN Stock Holding History

Virtu KCG Holdings’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$131K	Buy	15,285 +4,495	+42%	+$32.2K	﹤0.01%	2341
2017 Q1	$76K	Buy	+10,790	New	+$67.6K	﹤0.01%	2754
2016 Q1	–	Sell	-11,278	Closed	-$38K	–	3901
2015 Q4	$38K	Buy	+11,278	New	+$52.3K	﹤0.01%	3206
2015 Q1	–	Sell	-25,357	Closed	-$189K	–	4092
2014 Q4	$189K	Buy	+25,357	New	+$215K	﹤0.01%	2918

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu KCG Holdings's KIN Position: Q2 2017 in Review

Virtu KCG Holdings increased its Kindred Biosciences, Inc. (KIN) stake by 42% in Q2 2017, buying an estimated $32.2K and bringing the position to 15,285 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

Virtu KCG Holdings first reported a position in KIN in Q4 2014 and has held it in 4 quarters since. The position peaked at $189K in Q4 2014. 66 funds tracked by Wall St. Rank hold KIN as of Q2 2017.

Virtu KCG Holdings held 15,285 shares of Kindred Biosciences, Inc. worth $131K as of Q2 2017.
Virtu KCG Holdings bought 4,495 Kindred Biosciences, Inc. shares in Q2 2017, an estimated $32.2K.
Kindred Biosciences, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2341 holding.
Virtu KCG Holdings first reported a position in Kindred Biosciences, Inc. in Q4 2014 and has held it in 4 quarters since.
Virtu KCG Holdings's Kindred Biosciences, Inc. position peaked at $189K in Q4 2014.
66 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.